ASX:PAA

PHARMAUST LIMITED

MARKET CAP

-

Market data as of last close

4W AVG VOLUME

-

4W AVG TURNOVER

-

PHARMAUST LIMITED has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise

$250k - $500k

Investors Interested in Next Raise

< 10

How Fresh Equities Works

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

2. View Terms

View the full term sheet for the capital raise.

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

30 September 2019

Placement

Raised

$2.4m

Offer Price

$0.120

Discount

20%

Price at Close

$0.150

Market Cap

$42.21m

Re-listed

03-10-2019

Company Overview

PharmAust Limited (PAA) is a clinical-stage company developing targeted cancer therapeutics to address both human and animal healthcare. The company specialises in repurposing marketed drugs lowering the risks and costs of development. These efforts are supported by PAA’s subsidiary, Epichem, which is a highly successful contract medicinal chemistry company that generates significant annual revenues.

Type

Listed Company

GICS Sub-industry

Pharmaceuticals

Head Office

39/1 Freshwater Parade, Claremont WA 6010, Australia

Website

www.pharmaust.com

Cancer Therapeutics

Pharmaceuticals

Health Care

Biotech

Cancer

Biotech & Health

Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Directors

Dr Roger Aston

Executive Chairman

Robert Bishop

Executive Director

Neville John Bassett

Non-Executive Director

Sam Wright

Non-Executive Director

Announcements

News

[PRESENTATION] AGM Presentation
Posted at 9 November 2018.